|Day Low/High||0.36 / 0.38|
|52 Wk Low/High||0.36 / 1.18|
Here's a technical look at how to trade some of the most active stocks on the market right now.
Palatin appears be to playing a game of bait and switch with the design of its phase III studies.
Results of Phase 1 Study Demonstrate No Adverse Events When Bremelanotide is Combined with Ethanol
Stocks with insider trader activity include AEL, PTN and BSX
Palatin Technologies (PTN) shares are rising after the FDA approved the first treatment for low female libido earlier this week.
Palatin Technologies (PTN) shares are climbing after the FDA approved the first low female libido treatment yesterday.
Trade-Ideas LLC identified Palatin Technologies (PTN) as a strong on high relative volume candidate
Palatin Technologies (PTN) shares are up over 30% after an FDA advisory panel voted to approve a version of the company's low female libido treatment.